Cryomass Technologies, INC
Market Movers (8-K)
OTC.Pink
Cryomass Technologies Inc. has been moved from OTC Pink to the Expert Market due to non-current regulatory filings, restricting public viewing of quotations.
Delay expected
Worse than expected
OTC.Pink
Cryomass Technologies Inc. has secured $400,000 through a private placement with an accredited investor, issuing units consisting of common stock purchase warrants and pre-funded warrants.
Capital raise
OTC.Pink
CryoMass Technologies Inc. has sold a CryoSift Separator and licensed its cryogenic refinement technology to Tribe Collective and Choctaw Processing in Oklahoma, projecting potential recurring revenues exceeding $1,000,000 per annum.
Better than expected
OTC.Pink
8-K: CryoMass Technologies Sells Second CryoSift Unit to Cannabis Giant LEEF Brands in $1.2 Million Deal
CryoMass Technologies has sold its second CryoSift Separator for $1.2 million to LEEF Brands, a major California cannabis company, alongside a multi-party lease and patent agreement.
OTC.Pink
CryoMass Technologies has sold its first production model CryoSift Separator for CAD$1.62 million to a Canadian cannabis and hemp operator, marking a significant milestone for the company.
OTC.Pink
Cryomass Technologies has engaged Haynie & Company as their new independent registered public accounting firm, effective immediately for the fiscal year ending December 31, 2024.
Quarterly Earnings (10-Q)
OTC.Pink
Cryomass Technologies Inc. reported a net loss of $1.1 million for the third quarter of 2024, despite a small increase in revenue and a decrease in operating expenses.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Cryomass Technologies saw revenue growth in Q2 2024, but continues to experience net losses and going concern uncertainty.
Worse than expected
Capital raise
OTC.Pink
Cryomass Technologies saw a small increase in revenue but continued to experience net losses in the first quarter of 2024, alongside ongoing concerns about its ability to continue as a going concern.
Worse than expected
Capital raise
Annual Reports (10-K)
OTC.Pink
10-K: Cryomass Technologies Inc. Reports Full Year 2023 Results, Navigates Challenges in Evolving Market
Cryomass Technologies Inc. reports a net loss of $12.9 million for 2023, alongside strategic developments in its licensing and equipment rental agreements.
Delay expected
Capital raise
Worse than expected
Insider Trading (Form 4)
OTC.Pink
Christian Noel, CEO of Cryomass Technologies, reports indirect acquisitions of common stock through Trichome Capital Inc.